MedPath

checking the level of bone growth with and without application of vitamin c mixed with bone graft around teeth with bone loss

Phase 4
Recruiting
Conditions
Periodontal disease with bony defects
Registration Number
CTRI/2024/12/078436
Lead Sponsor
Dr N Sai Charitha
Brief Summary

AIM: The aim of the present study is to evaluate clinical and Radiographic evaluation of periodontal bony defects with and without Ascorbic acid admixed nano hydroxyappatite bone grafts

All the participants will be explained about the aim, nature and design of the study along with a written informed consent for their participation before the commencement of the study.



The study is planned as a randomized clinical trial conducted in healthy individuals with Periodontitis. the study duration is 9 months in which clinical parameters will be recorded at baseline, 1 month and 6 months. Radiographic parameters will be recorded at baseline, 1 month, 6 months and 9 months.



The study will be performed in accordance with the Helsinki Declaration of 1975, as revised in 2013.



The clinical parameters for assessment include



1. Periodontal Probing Depth



2. Clinical Attachment Levels.



3. Gingival Bleeding Index



The radiographic parameters for assessment include



1. amount of bone fill



2. percentage of bone fill



All the patients included in this study will be evaluated before the treatment procedure and patients with periodontal bony defects will be selected.



Two sites left and right halves of the maxillary or mandibular rch will be selected and assigned as test and control groups.



Test group: Ascorbic acid admixed nano hydroxyapatite bone graft



Control group: hydroxyapatitie graft



Procedure: a split mouth design will be followed, where the bilateral quadrants with bony defects will be chosen. 30 sites from 15 patients will be selected and grouped as test and control site.



Clinical parameters will be recorded at baseline, 1 month, and 6 months, radiographic parameters will be recorded at baseline, 1 month, 6 months and 9 months in both the test and control groups.



Open flap debridement will be performed to all patients and nano hydroxyapatite bone graft will be placed in control site and ascorbic acid admixed nano hydroxyapatite bone graft will be placed in test sites.



Post operative instructions will be given to all the patients and will be recalled after 1 week for suture removal.



In any case of discomfort, patients are advised to report back



All the patients will be recalled again after 1 month, 6 & 9 months for re-evaluation of clinical and radiographic parameters in both test and control groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Who are systemically healthy Both males and females with age ≥30 years having periodontitis with bilateral bony defects.
  • Pocket depths ≥5 mm after phase 1 evaluation.
  • Radiographic evidence of bone loss.
  • Participants who are co‑operative and able to come for regular follow-up.
  • Participants with ≥20 remaining teeth.
Exclusion Criteria
  • Pregnant/lactating women Individuals who are known allergic to ascorbic acid.
  • Who received antibiotic therapy in the previous 6 months Who underwent periodontal therapy in the past 6 months Use of tobacco in any form Medically compromised or under therapeutic regimen that may alter the probability of periodontal healing.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Periodontal probing depths(PD)baseline,one month,6 months & 9 months
Clinical attachment levels(CAL)baseline,one month,6 months & 9 months
amount of bone fillbaseline,one month,6 months & 9 months
Amount of bone fillbaseline,one month,6 months & 9 months
Secondary Outcome Measures
NameTimeMethod
Gingival Bleeding IndexPercentage Of Bonefill

Trial Locations

Locations (1)

Narayana Dental College And Hospital

🇮🇳

Nellore, ANDHRA PRADESH, India

Narayana Dental College And Hospital
🇮🇳Nellore, ANDHRA PRADESH, India
Dr N Sai Charitha
Principal investigator
8342144859
rajindisha.ss@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.